Indian drugs are cheaper says govt

NEW DELHI

Central govt. defended its decision to end the custom duty exemption for import of 76 LIFE SAVING DRUGS including those for the treating cancer, AIDS, Hemophilia. Government has said Indian manufacturers are already selling most of these drugs at cheaper prices.

Govt. also claimed there will only be marginal increases in prices of these imported drugs due to exemption withdrawl. Health ministry official also said ”In case of 95% of these drugs the custom duty is only 2.5%,so if there is a increase it would be very marginal .While  the medicine directly impact the treatment of crucial health problems like HIV ,AIDS and HAEMOPHILLIA, the official also said majority of such patients are treated by Govt. hospitals. The list of 76 medicines also contains pharmaceuticals ingredients.

A notification issued by CENTRAL BOARD OF EXCISE AND CUSTOMS had withdrawn the customs duty exemption on the impact of 76 drugs. They are used in treatment of diseases like PARKINSONS DISEASE, BONE DISEASES,KIDNEY STONES,BACTERIAL INFECTION, ARTHRITIS,LUPUS .

  • Related Posts

    Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical Specialties

    For commercial-scale production of 14 complex excipients The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties Private…

    Delhi High Court slams Baba Ramdev for new video targeting Rooh Afza

    The Delhi High Court on Thursday came down heavily on yoga guru Baba Ramdev for allegedly releasing a fresh video targeting Hamdard, despite an earlier undertaking to refrain from making…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharma launches TEVIMBRA in India

    India’s herbal and ayurvedic OTC market set to outpace global growth

    India’s herbal and ayurvedic OTC market set to outpace global growth

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug